Skip to content

GNLX

Genelux Corporation

NASDAQ · USHealthcareBiotechnology
$2.93+2.09%

Price as of Jul 20, 2026

GNLX capital

Genelux Corporation capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.11x
Net debt / equity
-0.30x
Debt / assets
0.08x
Debt / EBITDA
-0.08x
Net debt / EBITDA
0.21x

Liquidity & coverage

Current ratio
3.68x
Quick ratio
3.68x
Cash ratio
3.60x
Interest coverage
EBITDA / interest
Working capital
$19.5M

Cash & dividend

FCF / debt
-11.17x
Cash flow / debt
-10.38x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.